COMPLICATIONS OF BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY
- 1 August 1992
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 19 (3) , 565-572
- https://doi.org/10.1016/s0094-0143(21)00423-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder CancerJournal of Urology, 1992
- Clinical and Pathological Findings in Prostates Following Intravesical Bacillus Calmette-Guerin InstillationsJournal of Urology, 1990
- Fatal Disseminated Mycobacterial Infection Following Intravesical Bacillus Calmette-GuerinJournal of Urology, 1990
- Granulomatous Prostatitis Following Bacillus Calmette-Guerin Immunotherapy of Bladder CancerJournal of Urology, 1988
- Toxicity of intravesical BCG and its management in patients with superficial bladder tumorsCancer, 1987
- BCG (–RIVM) Versus MMc Intravesical Therapy in Patients with Superficial Bladder Cancer: First, Results of a Randomized Prospective TrialJournal of Urology, 1987
- Nephrogenic Adenoma Associated with Intravesical Bacillus Calmette-Guerin Treatment: A Report of 2 CasesJournal of Urology, 1986
- Intravesical Bacillus Calmette-Guerin Therapy and Associated Granulomatous Renal MassesJournal of Urology, 1986
- Immunotherapy of Murine Transitional Cell CarcinomaJournal of Urology, 1982
- Human toxicology of BCG applied in cancer immunotherapyCancer Immunology, Immunotherapy, 1976